WHO consultancy to support AMR-related messaging / 2 Mar 2020 deadline!

Dear All,

WHO has just posted a job opening for a consultant in Geneva to help with spreading the word about AMR by (i) revamping the World Antibiotic Awareness Week (WAAW) campaigns and (ii) facilitating mainstreaming of antimicrobial resistance messages into major global events and scientific conferences. Full details from the posting are below my signature and the deadline for applications is 2 Mar 2020!

This looks like a fun role … get busy with your application! All best wishes, –jr

John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Operating Partner, Advent Life Sciences. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: https://amr.solutions/blog/


Contract type: Consultancy
Application Deadline: 2nd March 2020
Contact: Rosalie Edma
Email address: edmar@who.int
Consultancy Reference: AMR/GCP/2020/#3
 
Purpose of the Consultancy: Support the revamping of the World Antibiotic Awareness Week (WAAW) campaigns and facilitate the mainstreaming of antimicrobial resistance messages into major global events and scientific conferences.
 
Background: The Department of Global Coordination and Partnership on Antimicrobial Resistance (GCP) leads and coordinates the global One Health response to antimicrobial resistance through facilitating and managing strategic and innovative partnerships and providing secretariat services to global governance mechanisms on antimicrobial resistance in collaboration with the FAO, OIE  and other UN and international agencies as well as Member States and partners including the civil society and private sector. The Department facilitates the implementation of the recommendations of the UN Interagency Coordination Group on Antimicrobial resistance, strengthen evidence-based and coordinated response against antimicrobial resistance across the One Health spectrum in humans, animals, plants, food, feed and the environment through the development and implementation of global vision, goals and targets, political advocacy and engagement, and facilitating innovative partnerships and contributes towards the achievement of the SDGs. It also promotes synergy, set priorities and advocate to unblock bottlenecks for research and development for antimicrobial resistance across the One Health spectrum.
 
Work to be performed
The consultant will support the revamping of the World Antibiotic Awareness Week (WAAW) campaigns and mainstreaming of antimicrobial resistance messages into major global events and scientific conferences through. 

  • Liaise with Tripartite organisations, WHO regional and country offices and other stakeholders, and ensure advocacy and awareness materials are delivered in a timely fashion for WAAW;
  • Identify global advocacy opportunities and develop strategies to mainstream antimicrobial resistance containment and mitigation interventions
  • Assist the development of advocacy and awareness materials in various formats and media aligned with overall global narrative on AMR as a key global public health issue in one health context;

 
Deliverables

  1. A roadmap outlining the key steps to revamp WAAW campaigns based on best practices and experiences, evidence and country specific requirements in close collaboration with the Tripartite organisations and partners;
  2. High quality advocacy and awareness raising documents for mainstreaming AMR containment and mitigation messages into major global events and scientific conferences
  3. Other related duties, as required by the supervisor and the Department.

 
Requirements for qualifications and experiences

  • Educational Qualifications:  
    • Essential: Advanced degree in social sciences or public health 
  • WHO Competencies
    • Communicating in a credible and effective way
    • Producing results
    • Knowing and managing yourself
    • Moving forward in a changing environment

 
Experience required:

  • Essential:
    • At least seven years of progressive work experience in public health including on global advocacy
    • Project management skills combined with strong technical writing skills for different audiences
  • Desirable:
    • Demonstrable knowledge and skill in developing online and social media campaigns
    • Knowledge of antimicrobial resistance and communicable disease
    • Experience in organising public health campaigns

Language requirements:
Essential: Expert knowledge of English.
Desirable: Knowledge of other WHO official language would be an asset
 
Place of assignment:
The place of assignment will be WHO Headquarters, Geneva, Switzerland
 
If you are interested to apply, please send your CV and motivational letter to edmar@who.int not later than 2 March 2020

Current funding opportunities:

  • Open now through 28 Feb 2020: FDA call for applications to create rabbit models of ventilator-associated bacterial pneumonia (VAP or VABP, depending on your preferred abbreviation) due to carbapenem-resistant strains of A. baumannii and P. aeruginosa. Go here for details.
  • Open now through 16 Mar 2020: CC4CARB, NIAID’s call for applications to fund an innovative Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB). Go here for details.
  • Open now through 9 Apr 2020: NIAID Broad Agency Announcement (BAA) soliciting contract proposals for preclinical and clinical development of vaccines, therapeutic, and diagnostics for microbial pathogens. Go here for more.
  • Dates for the 2020 funding rounds for Novo REPAIR Impact Fund will be announced May 2020. Go here for current details.
  • 2020 funding rounds for CARB-X have not been announced.


Upcoming meetings of interest to the AMR community:

  • Unclear dates. University of Sheffield (UK). Applications are being taken for a new 1-year (full-time) or 2-year (part-time) Masters of Science course in Antimicrobial Resistance. The program appears to start Fall 2020. The course webpage is here. Further details when I have them!
  • 26-27 Feb 2020 (Washington, DC): US PACCARB public meeting. Go here for details.
  • 27 Feb 2020 (1700-1830 CET, online): GARDP-sponsored webinar entitled “PK/PD murine infection models: Focus on study elements, variability, and interpretation of results.” Go here to register.
  • 1-6 Mar 2020 (Il Ciocco, Tuscany, Italy): Gordon Research Conference (GRC) on Antibacterial Discovery and Development: “Now is the time to re-boot antibiotic R&D before it’s too little, too late.” Go here for details.
  • 5 Mar 2020 (FDA, White Oak Campus, 8.30a-5.00p EST): FDA workshop entitled “Advancing Animal Models for Antibacterial Drug Development.” FR notice is here and registration is here. The workshop will be webcast.
  • 12-13 Mar 2020 (Basel): BEAM-, Novo REPAIR-, CARB-X-, DZIF-, ND4BB-, ENABLE-supported (among a long list!) Conference on Novel Antimicrobials and AMR Diagnostics. Details are here, poster deadline is 12 Dec 2019.  
  • 16-17 Mar 2020 (London): BSAC Spring Conference entitled: “Bridging the gap between science, policy and effective antimicrobial use.” Go here for details. 
  • [UPDATED – REGISTRATION IS NOW OPEN] 20 Mar 2020 (Boston, MA): 7th annual BAARN (Boston Area Antimicrobial Resistance Network) Meeting. Chaired by Lawson Ung and Michael Gilmore, talks start at 9am and end with a reception at the Harvard Museum of Natural History. Go here to register; you can also contact Lawson Ung (lawson_ung@meei.harvard.edu) for other inquiries.
  • 26-30 Mar 2020 (Atlanta, GA): CDC- and SHEA-sponsored 6th International Conference on Healthcare Associated Infections. Go here for details.
  • 30 Mar 2020 (everywhere): Deadline for applications for the Molecular Mycology pathogenesis course at Marine Biological Laboratory, Woods Hole. Now in its 24th year, the hands-on residential course runs 17 July to 2 Aug and gets rave reviews. Go here for more.
  • 9 Apr 2020 (everywhere): Final date for applications for NIAID/DMID call (link) for AMR-related vaccines, therapeutics, and diagnostics.
  • [NEW] 17 Apr 2020 (Paris): Pre-ECCMID workshop entitled “Machine Learning for Clinical Microbiology”. Go here for details. 
  • 18-21 Apr 2020 (Paris): Annual ECCMID meeting (#30)
  • 25-30 May 2020 (Rotterdam), Annual ESPID meeting (European Society for Pediatric ID, #38)
  • 18-22 Jun 2020 (Chicago), ASM Microbe 2020. Go here for details.
  • 27-28 Jun 2020 (Bryant University, Rhode Island): Drug Resistance Gordon Research Seminar entitled “Mechanisms and Approaches to Overcoming Drug Resistance in Cancer, Infectious Disease and Agriculture” for graduate students and postdoctoral scientists. Go here for details … this immediately precedes the GRC listed just next
  • 28 Jun-3 Jul 2020 (Bryant University, Rhode Island): Gordon Research Conference (GRC) entitled “Strategies to Disrupt Drug Resistance in Infectious Disease, Cancer and Agriculture.” Go here for details.
  • 1-4 Sep 2020 (Dublin): Annual ASM-ESCMID Conference on Antibiotic Development #5! Mark your calendar now and go here for details.
  • 9-10 Sep 2020 (Washington, DC): US PACCARB public meeting. Go here for details.
  • 22-25 Sep 2020 (Albuquerque, New Mexico): Biannual meeting of the MSGERC (Mycoses Study Group Education and Research Consortium). Save-the-date announcement is here, details to follow.
  • 17-25 Oct 2020 (Annecy, France): Interdisciplinary Course on Antibiotics and Resistance (ICARe). This is a soup-to-nuts residential course on antibiotics, antibiotic resistance, and antibiotic R&D. The course is very intense, very detailed, and gets rave reviews. The date is set for 2020 and the program will ultimately appear here. Registration is limited to 40 students and opens 15 Mar 2020.
  • 10-13 Apr 2021 (Vienna): Annual ECCMID meeting (#31)
  • 3-7 Jun 2021 (Anaheim), ASM Microbe 2021. Go here for details.

Share

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on whatsapp
Share on reddit

AMR Action Fund ($1b for P2-3): Video chat with new CEO! New committed funds!

Dear All, I’ve written before about the AMR Action Fund (9 Jul 2020 newsletter): In brief, it is ~$1b pledged by over 20 leading pharmaceutical companies to support the Phase 2-3 studies needed to bring 2-4 new antibiotics to approval by 2030 Stated differently, the AMR Action Fund provides Push incentives for Phase 2-3 to complement the Push Incentives

UK Antibiotic Subscription Pilot: Updates from a webinar

Dear All (and with thanks to Kevin Outterson for co-authoring), We’ve written and talked before from various perspectives about the groundbreaking UK NHS England-, NHS Improvement-, and NICE-sponsored antibiotic subscription pilot project: 10 Feb 2021: Fabulous 5-minute video explainer on the economics of antibiotics by Andrew Jack of Financial Times Superb discussions of Push/Pull, the role

Brilliant 5-minute video explainer of the AMR problem!

 Dear All, Andrew Jack of the Financial Times (FT) has produced a superb 5-minute video explainer of the AMR challenge! Featuring cameos from Kevin Outterson (CARB-X), Christine Ardal (Norwegian Institute of Public Health), and Manica Balasegaram (GARDP), the video deftly illustrates the economic challenge, the way that delinked Netflix-like models provide a solution, and the

Job with global impact: Director, CIDRAP Antimicrobial Stewardship Program

Dear All, Launched in 2016, the Antimicrobial Stewardship Program (ASP) at the Center for Infectious Disease Research and Policy (CIDRAP) of the University of Minnesota works to provide support globally to the the infectious disease community via such diverse activities as ASP-oriented podcasts, webinars, journal clubs, and other resources. CIDRAP itself is directed by the

Scroll to Top